JNBA Financial Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.51K Buy
26
+11
+73% +$2.16K ﹤0.01% 597
2026
Q1
$2.94K Hold
15
﹤0.01% 691
2025
Q4
$2.6K Hold
15
﹤0.01% 649
2025
Q3
$2.86K Hold
15
﹤0.01% 591
2025
Q2
$2.69K Hold
15
﹤0.01% 577
2025
Q1
$2.54K Hold
15
﹤0.01% 582
2024
Q4
$2.26K Hold
15
﹤0.01% 585
2024
Q3
$2.33K Hold
15
﹤0.01% 595
2024
Q2
$2.05K Hold
15
﹤0.01% 579
2024
Q1
$2K Hold
15
﹤0.01% 607
2023
Q4
$2.07K Hold
15
﹤0.01% 614
2023
Q3
$1.83K Hold
15
﹤0.01% 633
2023
Q2
$2.11K Hold
15
﹤0.01% 615
2023
Q1
$2.12K Hold
15
﹤0.01% 618
2022
Q4
$2.35K Hold
15
﹤0.01% 577
2022
Q3
$2K Hold
15
﹤0.01% 597
2022
Q2
$2K Hold
15
﹤0.01% 636
2022
Q1
$2K Hold
15
﹤0.01% 624
2021
Q4
$3K Hold
15
﹤0.01% 680
2021
Q3
$2K Hold
15
﹤0.01% 664
2021
Q2
$2K Hold
15
﹤0.01% 615
2021
Q1
$2K Hold
15
﹤0.01% 592
2020
Q4
$2K Hold
15
﹤0.01% 549
2020
Q3
$2K Hold
15
﹤0.01% 511
2020
Q2
$2K Hold
15
﹤0.01% 503
2020
Q1
$1K Hold
15
﹤0.01% 530
2019
Q4
$2K Buy
+15
New +$1.56K ﹤0.01% 550
2016
Q4
Sell
-541
Closed -$46K 694
2016
Q3
$46K Buy
+541
New +$45.4K 0.01% 550

Other funds holding DGX

JNBA Financial Advisors's DGX Position: Q2 2026 in Review

JNBA Financial Advisors increased its Quest Diagnostics (DGX) stake by 73% in Q2 2026, buying an estimated $2.16K and bringing the position to 26 shares worth $5.51K. The position accounts for ﹤0.01% of the portfolio, ranked #597.

JNBA Financial Advisors first reported a position in DGX in Q3 2016 and has held it in 28 quarters since. The position peaked at $46K in Q3 2016. 478 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • JNBA Financial Advisors held 26 shares of Quest Diagnostics worth $5.51K as of Q2 2026.
  • JNBA Financial Advisors bought 11 Quest Diagnostics shares in Q2 2026, an estimated $2.16K.
  • Quest Diagnostics made up ﹤0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #597 holding.
  • JNBA Financial Advisors first reported a position in Quest Diagnostics in Q3 2016 and has held it in 28 quarters since.
  • JNBA Financial Advisors's Quest Diagnostics position peaked at $46K in Q3 2016.
  • 478 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.